Eduardo Rodriguez Almaraz
SENIOR CRC SUPERVISOR
Neurological Surgery
School of Medicine

Education & Training

Show all (3) Hide

• MAS Clinical Research University of California, San Francisco 06/2019
• MD Medicine National Polytechnic Institute 11/2012
• PhD Epidemiology and Translational Science (DE: Computational Precision Health) University of California, San Francisco

Interests

Show all (9) Hide

• Neuro Oncology
• Oncology Clinical Trials
• Precision Medicine
• Machine Learning
• Quality of Life
• Cannabis and glioma
• SMART studies
• AI in Cancer
• Cancer genetics

Videos

Show all (1) Hide

• Medical Cannabis for Those Living With Brain Tumors: What Do We Really Know? (youtube.com)

Grants and Projects

Show all (3) Hide

• Identification of actionable mutations in IDH-mutant gliomas using next generation sequencing (UCSF 500), UCSF - Molecular oncology program, 2022-2023
• , Sullivan Grant, 2020-2022
• Impact of Cannabis and synthetic cannabinoid use on quality of life of patients with central nervous system tumors (ICANCNS-QoL), , 2018

Publications (10)

Top publication keywords:
HumansQuality of LifeBrain NeoplasmsCannabidiolCannabisCannabinoids

• Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis).
  Current treatment options in oncology 2023 Rodriguez-Almaraz JE, Butowski N
• Neuro-Oncology
  Retroelement expression in glioma tumors exhibits subtype specific patterns 2022 JE Rodriguez Almaraz, G Guerra, G Wendt, S Chang, S S Francis
• Neuro-Oncology
  BIOM-07. Quantitative MGMT Promoter Methylation Index indicates a non-linear prognostic effect in glioblastoma, suggesting that use of optimal cutoff points may be clinically disadvantageous 2021 Gibson, D., Ravi, A., Rodriguez Almaraz E. , Chang, S., Oberheim-Bush, N. A., Taylor, J., Clarke, J., Solomon, D., Scheffler, A., Witte, J., Lambing, H., Berger, M., Okada, H., Chehab, F., & Butowski,…
• Journal of Clinical Oncology
  Pilot trial treating recurrent GBM patients with precision medicine regimens. 2021 Jennifer Leigh Clarke, David Solomon, Nancy Ann Oberheim Bush, Jennifer A. Grabowsky, Cassie Kline, Deanna L. Kroetz, Jennie Webster Taylor, Javier Villanueva-Meyer, Annette Molinaro, David Gibson, …
• A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant central nervous system tumors
  A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant central nervous system tumors 2020 Eduardo Rodriguez Almaraz, MD, MAS, Susan Chang, MD, Jennifer Clarke, MD, MPH, Nancy Ann Oberheim-Bush, MD, PhD, Jennie Taylor, MD, Robin Buerki, MD, Mitchell Berger, MD, Lydia Zablotska, MD, PhD, …

Show all (5 more) Hide

• PI3K/mTOR Pathway Activation Selected Phase II Study of Everolimus (RAD001) with and without Temozolomide in the treatment of Adult Patients with supratentorial low-grade glioma
  PI3K/mTOR Pathway Activation Selected Phase II Study of Everolimus (RAD001) with and without Temozolomide in the treatment of Adult Patients with supratentorial low-grade glioma. 2019 Jennie Taylor, Annette Molinaro, Eduardo Rodriguez Almaraz, Ciara Downey, Joanna Phillips, Nancy Ann Oberheim-Bush, Nicholas Butowski, Susan Chang, Mitchel Berger, Michael Prados, Daphne Haas-Kogan, …
• Impact of cannabis use on quality of life in patients with central nervous system tumors
  Impact of cannabis use on quality of life in patients with central nervous system tumors 2019 J E Rodriguez Almaraz, S M Chang, N A E Oberheim-Bush, J R Clarke, J W Taylor, R A Buerki, M S Berger, N A Butowski
• Clinical experience with short-term-combined formula as pharmacological treatment (extended release) in the management of obesity
  Clinical experience with short-term-combined formula as pharmacological treatment (extended release) in the management of obesity 2014 Morin-Zaragoza R, Rodriguez-Choreno JD, Morales-Suarez MO, Rodriguez Almaraz JE.
• Mexican Contributions to the study of Obesity. Pharmacology chapter
  Mexican Contributions to the study of Obesity. Pharmacology chapter 2014 Leija, Gerardo.
• Possible mechanisms involved in the vasorelaxant effect produced by fenproporex in aortic segments of rats
  Possible mechanisms involved in the vasorelaxant effect produced by fenproporex in aortic segments of rats. 2013 Lopez-Canales JS, Lozano-Cuenca J, Morin-Zaragoza R, Rodriguez Almaraz JE.